![Michael Bakes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Michael Bakes currently works as the President, Chief Operating Officer & Director at Dose Therapeutics, Inc.
Aktive Positionen von Michael Bakes
Unternehmen | Position | Beginn |
---|---|---|
Dose Therapeutics, Inc.
![]() Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Dose Therapeutics, Inc.
![]() Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Commercial Services |